 Paul Buehler
Concepts (478)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemoglobins | 65 | 2024 | 339 | 11.230 |
Why?
| | Haptoglobins | 23 | 2022 | 52 | 4.360 |
Why?
| | Hemopexin | 11 | 2025 | 27 | 3.590 |
Why?
| | Anemia, Sickle Cell | 16 | 2025 | 254 | 3.430 |
Why?
| | Erythrocytes | 26 | 2025 | 672 | 3.340 |
Why?
| | Oxygen | 26 | 2024 | 915 | 3.320 |
Why?
| | Blood Substitutes | 15 | 2024 | 24 | 2.830 |
Why?
| | Hemolysis | 21 | 2025 | 199 | 2.720 |
Why?
| | Erythrocyte Transfusion | 9 | 2024 | 181 | 2.220 |
Why?
| | Extracellular Vesicles | 3 | 2023 | 130 | 2.010 |
Why?
| | Thrombin | 7 | 2023 | 146 | 1.980 |
Why?
| | Heme | 15 | 2025 | 77 | 1.900 |
Why?
| | Guinea Pigs | 23 | 2024 | 157 | 1.830 |
Why?
| | Iron | 16 | 2025 | 288 | 1.600 |
Why?
| | Fibrinolysin | 4 | 2022 | 18 | 1.560 |
Why?
| | Homeostasis | 3 | 2020 | 611 | 1.490 |
Why?
| | Kidney | 13 | 2020 | 1385 | 1.430 |
Why?
| | Oxidation-Reduction | 26 | 2020 | 1033 | 1.310 |
Why?
| | Transferrin | 4 | 2018 | 42 | 1.220 |
Why?
| | Complement C1 Inhibitor Protein | 4 | 2023 | 11 | 1.210 |
Why?
| | Animals | 79 | 2025 | 35360 | 1.140 |
Why?
| | Blood Transfusion | 6 | 2021 | 296 | 1.130 |
Why?
| | Blood Preservation | 10 | 2023 | 271 | 1.130 |
Why?
| | Thrombosis | 4 | 2022 | 343 | 1.010 |
Why?
| | Oxyhemoglobins | 5 | 2021 | 21 | 1.000 |
Why?
| | Oximetry | 3 | 2021 | 87 | 0.930 |
Why?
| | Hydrogen Peroxide | 12 | 2021 | 318 | 0.900 |
Why?
| | Thrombomodulin | 3 | 2022 | 10 | 0.860 |
Why?
| | Thrombotic Microangiopathies | 2 | 2020 | 15 | 0.830 |
Why?
| | Apoproteins | 3 | 2020 | 13 | 0.810 |
Why?
| | Hypercholesterolemia | 1 | 2023 | 102 | 0.800 |
Why?
| | Electron Spin Resonance Spectroscopy | 6 | 2023 | 91 | 0.800 |
Why?
| | Oxidative Stress | 16 | 2025 | 1269 | 0.780 |
Why?
| | Ascorbic Acid | 6 | 2019 | 120 | 0.780 |
Why?
| | Cation Transport Proteins | 3 | 2022 | 132 | 0.760 |
Why?
| | Drug Design | 3 | 2021 | 156 | 0.750 |
Why?
| | Shock, Hemorrhagic | 1 | 2023 | 165 | 0.740 |
Why?
| | Antibodies, Bispecific | 1 | 2021 | 49 | 0.710 |
Why?
| | Lipids | 3 | 2023 | 625 | 0.700 |
Why?
| | Purpura, Thrombotic Thrombocytopenic | 1 | 2020 | 12 | 0.700 |
Why?
| | Hemolytic-Uremic Syndrome | 1 | 2020 | 13 | 0.700 |
Why?
| | Hematologic Diseases | 2 | 2018 | 61 | 0.690 |
Why?
| | Nitric Oxide | 11 | 2021 | 902 | 0.690 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 7 | 2021 | 60 | 0.680 |
Why?
| | Polymers | 6 | 2024 | 479 | 0.670 |
Why?
| | Hemophilia A | 1 | 2021 | 115 | 0.660 |
Why?
| | Humans | 92 | 2025 | 129622 | 0.660 |
Why?
| | Recombinant Proteins | 4 | 2021 | 1304 | 0.660 |
Why?
| | Blood Coagulation Disorders | 1 | 2020 | 167 | 0.610 |
Why?
| | Vascular Diseases | 3 | 2024 | 241 | 0.600 |
Why?
| | Receptors, Cell Surface | 7 | 2021 | 380 | 0.590 |
Why?
| | Transfusion Reaction | 3 | 2020 | 43 | 0.580 |
Why?
| | Antigens, CD | 7 | 2021 | 489 | 0.560 |
Why?
| | Lipoproteins | 1 | 2018 | 171 | 0.560 |
Why?
| | beta-Thalassemia | 3 | 2025 | 37 | 0.550 |
Why?
| | Biomarkers | 6 | 2020 | 3973 | 0.540 |
Why?
| | Lipid Peroxidation | 8 | 2018 | 151 | 0.510 |
Why?
| | Acute Kidney Injury | 4 | 2018 | 790 | 0.500 |
Why?
| | Hemochromatosis | 1 | 2015 | 8 | 0.480 |
Why?
| | beta-Globins | 1 | 2015 | 8 | 0.480 |
Why?
| | Spleen | 4 | 2025 | 507 | 0.470 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2025 | 30 | 0.460 |
Why?
| | Hypertension, Pulmonary | 5 | 2025 | 1894 | 0.450 |
Why?
| | Exercise Tolerance | 3 | 2025 | 273 | 0.430 |
Why?
| | Rats, Sprague-Dawley | 10 | 2024 | 2406 | 0.430 |
Why?
| | Glutaral | 3 | 2012 | 15 | 0.430 |
Why?
| | Inflammation | 4 | 2023 | 2736 | 0.430 |
Why?
| | Gene Deletion | 1 | 2015 | 379 | 0.420 |
Why?
| | Rats | 15 | 2024 | 5499 | 0.420 |
Why?
| | Peroxidases | 3 | 2015 | 33 | 0.410 |
Why?
| | Lung | 5 | 2025 | 3931 | 0.410 |
Why?
| | Disease Models, Animal | 13 | 2025 | 4063 | 0.400 |
Why?
| | Polyethylene Glycols | 5 | 2024 | 601 | 0.400 |
Why?
| | Models, Animal | 4 | 2020 | 376 | 0.390 |
Why?
| | Blood Coagulation | 4 | 2022 | 238 | 0.390 |
Why?
| | Male | 40 | 2025 | 63674 | 0.390 |
Why?
| | Receptors, Scavenger | 6 | 2021 | 21 | 0.390 |
Why?
| | Macrophages | 6 | 2023 | 1480 | 0.390 |
Why?
| | Cattle | 9 | 2022 | 976 | 0.360 |
Why?
| | Sodium Nitrite | 1 | 2011 | 39 | 0.360 |
Why?
| | Central Nervous System Diseases | 1 | 2011 | 68 | 0.340 |
Why?
| | Drug Carriers | 2 | 2008 | 118 | 0.340 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2011 | 274 | 0.340 |
Why?
| | Heme Oxygenase-1 | 8 | 2025 | 62 | 0.330 |
Why?
| | Biopolymers | 1 | 2010 | 33 | 0.330 |
Why?
| | Mice | 16 | 2025 | 16937 | 0.330 |
Why?
| | Heme Oxygenase (Decyclizing) | 6 | 2013 | 22 | 0.330 |
Why?
| | Biological Transport | 2 | 2021 | 401 | 0.330 |
Why?
| | Biological Products | 3 | 2022 | 202 | 0.320 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 9 | 2015 | 137 | 0.320 |
Why?
| | Lung Diseases | 2 | 2015 | 742 | 0.320 |
Why?
| | Analgesics, Opioid | 3 | 2024 | 913 | 0.320 |
Why?
| | Protein Binding | 8 | 2021 | 2121 | 0.320 |
Why?
| | Molecular Weight | 6 | 2024 | 332 | 0.320 |
Why?
| | Erythrocyte Deformability | 2 | 2023 | 15 | 0.320 |
Why?
| | Central Nervous System | 1 | 2011 | 257 | 0.310 |
Why?
| | Hemodynamics | 4 | 2023 | 1089 | 0.310 |
Why?
| | Amino Acids | 4 | 2021 | 485 | 0.300 |
Why?
| | Microvessels | 2 | 2020 | 83 | 0.300 |
Why?
| | Liver | 4 | 2025 | 1839 | 0.300 |
Why?
| | Endothelial Cells | 4 | 2024 | 749 | 0.300 |
Why?
| | Proteome | 3 | 2025 | 443 | 0.290 |
Why?
| | Hypoxia | 6 | 2019 | 1084 | 0.290 |
Why?
| | Erythrocyte Indices | 2 | 2019 | 27 | 0.280 |
Why?
| | Glucosephosphate Dehydrogenase | 2 | 2025 | 56 | 0.280 |
Why?
| | Plasma Exchange | 1 | 2007 | 12 | 0.280 |
Why?
| | Erythropoiesis | 2 | 2019 | 51 | 0.280 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2019 | 2012 | 0.280 |
Why?
| | Proteomics | 7 | 2025 | 1062 | 0.270 |
Why?
| | Signal Transduction | 4 | 2019 | 4925 | 0.270 |
Why?
| | Uric Acid | 1 | 2008 | 161 | 0.270 |
Why?
| | Myocardium | 4 | 2019 | 980 | 0.260 |
Why?
| | Blood Circulation | 1 | 2005 | 41 | 0.250 |
Why?
| | Opioid-Related Disorders | 2 | 2024 | 484 | 0.250 |
Why?
| | Methemoglobin | 4 | 2021 | 20 | 0.240 |
Why?
| | Vascular Remodeling | 2 | 2019 | 192 | 0.240 |
Why?
| | Circular Dichroism | 2 | 2021 | 148 | 0.240 |
Why?
| | Mice, Inbred C57BL | 9 | 2025 | 5440 | 0.240 |
Why?
| | Chromatography, Gel | 5 | 2010 | 127 | 0.240 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.230 |
Why?
| | Antioxidants | 1 | 2008 | 559 | 0.230 |
Why?
| | Riboflavin | 1 | 2024 | 7 | 0.230 |
Why?
| | Vasoconstriction | 4 | 2020 | 199 | 0.220 |
Why?
| | Vascular Resistance | 2 | 2016 | 371 | 0.220 |
Why?
| | Nitrogen Oxides | 1 | 2004 | 52 | 0.220 |
Why?
| | Aspirin | 2 | 2006 | 380 | 0.220 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2023 | 23 | 0.220 |
Why?
| | Muscle, Skeletal | 3 | 2025 | 1614 | 0.220 |
Why?
| | Nails | 1 | 2023 | 11 | 0.220 |
Why?
| | Endothelium, Vascular | 3 | 2018 | 901 | 0.210 |
Why?
| | Hemoglobin A | 4 | 2006 | 22 | 0.210 |
Why?
| | Intercellular Adhesion Molecule-1 | 2 | 2015 | 135 | 0.210 |
Why?
| | Perfusion | 1 | 2024 | 197 | 0.210 |
Why?
| | Blood Pressure | 6 | 2018 | 1735 | 0.200 |
Why?
| | Equidae | 1 | 2022 | 4 | 0.200 |
Why?
| | Protein Engineering | 2 | 2018 | 105 | 0.200 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 229 | 0.200 |
Why?
| | Radiation Injuries | 1 | 2023 | 135 | 0.200 |
Why?
| | Species Specificity | 2 | 2020 | 575 | 0.200 |
Why?
| | Superoxides | 1 | 2022 | 201 | 0.190 |
Why?
| | Receptors, Thrombin | 1 | 2022 | 12 | 0.190 |
Why?
| | Receptor, PAR-1 | 1 | 2022 | 21 | 0.190 |
Why?
| | Fibrinolysis | 2 | 2022 | 137 | 0.190 |
Why?
| | Intestinal Absorption | 1 | 2002 | 99 | 0.190 |
Why?
| | Mycoplasma hyorhinis | 1 | 2021 | 1 | 0.190 |
Why?
| | Methemoglobinemia | 2 | 2015 | 13 | 0.190 |
Why?
| | Magnetics | 1 | 2021 | 44 | 0.190 |
Why?
| | Ultraviolet Rays | 1 | 2024 | 383 | 0.190 |
Why?
| | Blood Coagulation Tests | 1 | 2021 | 60 | 0.190 |
Why?
| | Cell Line | 6 | 2015 | 2781 | 0.180 |
Why?
| | Tranexamic Acid | 1 | 2021 | 37 | 0.180 |
Why?
| | Models, Biological | 4 | 2018 | 1722 | 0.180 |
Why?
| | Antifibrinolytic Agents | 1 | 2021 | 47 | 0.180 |
Why?
| | Methemalbumin | 1 | 2021 | 1 | 0.180 |
Why?
| | Factor VIII | 1 | 2021 | 87 | 0.180 |
Why?
| | Photoelectron Spectroscopy | 1 | 2021 | 6 | 0.180 |
Why?
| | Lung Transplantation | 1 | 2024 | 289 | 0.180 |
Why?
| | Free Radicals | 4 | 2015 | 106 | 0.180 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 65 | 0.180 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 32 | 0.180 |
Why?
| | Pulmonary Artery | 3 | 2019 | 1096 | 0.180 |
Why?
| | Polymerization | 3 | 2023 | 124 | 0.170 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2020 | 34 | 0.170 |
Why?
| | Beta vulgaris | 1 | 2020 | 11 | 0.170 |
Why?
| | CD40 Antigens | 1 | 2021 | 88 | 0.170 |
Why?
| | Hypertension | 3 | 2020 | 1242 | 0.170 |
Why?
| | Pharmaceutical Preparations | 1 | 2002 | 171 | 0.170 |
Why?
| | Subarachnoid Space | 1 | 2019 | 8 | 0.170 |
Why?
| | Membrane Lipids | 1 | 2020 | 91 | 0.170 |
Why?
| | Vasospasm, Intracranial | 1 | 2019 | 17 | 0.170 |
Why?
| | Cell-Derived Microparticles | 1 | 2020 | 67 | 0.170 |
Why?
| | Protein Unfolding | 1 | 2019 | 31 | 0.160 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 284 | 0.160 |
Why?
| | Biotechnology | 1 | 2019 | 40 | 0.160 |
Why?
| | Blood Specimen Collection | 1 | 2019 | 35 | 0.160 |
Why?
| | Rats, Inbred Lew | 1 | 2019 | 110 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2019 | 72 | 0.160 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2019 | 64 | 0.160 |
Why?
| | Nitrates | 2 | 2020 | 89 | 0.160 |
Why?
| | Blotting, Western | 5 | 2015 | 1205 | 0.160 |
Why?
| | Ferritins | 2 | 2010 | 58 | 0.160 |
Why?
| | Osmotic Fragility | 2 | 2024 | 7 | 0.160 |
Why?
| | Toxicokinetics | 1 | 2018 | 9 | 0.160 |
Why?
| | Equipment and Supplies | 1 | 2019 | 41 | 0.150 |
Why?
| | Cell Communication | 1 | 2020 | 301 | 0.150 |
Why?
| | Erythropoietin | 2 | 2018 | 86 | 0.150 |
Why?
| | Antibodies | 1 | 2021 | 398 | 0.150 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 42 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2020 | 333 | 0.150 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2548 | 0.150 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 178 | 0.150 |
Why?
| | Healthy Volunteers | 1 | 2019 | 200 | 0.150 |
Why?
| | Recombinant Fusion Proteins | 1 | 2021 | 643 | 0.150 |
Why?
| | Fibrin | 1 | 2019 | 70 | 0.150 |
Why?
| | Lipocalin-2 | 1 | 2018 | 75 | 0.150 |
Why?
| | Plasma | 1 | 2020 | 206 | 0.150 |
Why?
| | Kidney Function Tests | 1 | 2018 | 152 | 0.150 |
Why?
| | Anemia | 1 | 2019 | 160 | 0.150 |
Why?
| | Liver Diseases | 1 | 2021 | 290 | 0.150 |
Why?
| | Female | 16 | 2023 | 68770 | 0.140 |
Why?
| | Metabolic Clearance Rate | 2 | 2012 | 118 | 0.140 |
Why?
| | Neutrophil Activation | 1 | 2018 | 79 | 0.140 |
Why?
| | Temperature | 1 | 2021 | 636 | 0.140 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 330 | 0.140 |
Why?
| | Models, Cardiovascular | 1 | 2019 | 191 | 0.140 |
Why?
| | Hepcidins | 2 | 2015 | 22 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2018 | 958 | 0.140 |
Why?
| | Serine Endopeptidases | 1 | 2018 | 118 | 0.140 |
Why?
| | Treatment Outcome | 3 | 2019 | 10226 | 0.140 |
Why?
| | Physical Exertion | 1 | 2018 | 205 | 0.140 |
Why?
| | Solutions | 2 | 2010 | 151 | 0.140 |
Why?
| | Metabolomics | 4 | 2025 | 652 | 0.140 |
Why?
| | Oxymorphone | 1 | 2016 | 3 | 0.140 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 31 | 0.140 |
Why?
| | Dogs | 3 | 2022 | 381 | 0.130 |
Why?
| | Proteins | 1 | 2023 | 942 | 0.130 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 334 | 0.130 |
Why?
| | Disease Management | 1 | 2020 | 589 | 0.130 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 204 | 0.130 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1706 | 0.130 |
Why?
| | Swine | 4 | 2021 | 760 | 0.130 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 759 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2021 | 499 | 0.130 |
Why?
| | Microcirculation | 2 | 2020 | 145 | 0.130 |
Why?
| | Sepsis | 2 | 2020 | 574 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 341 | 0.120 |
Why?
| | Human Umbilical Vein Endothelial Cells | 4 | 2018 | 101 | 0.120 |
Why?
| | Disease Progression | 3 | 2023 | 2635 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 335 | 0.120 |
Why?
| | Spin Trapping | 1 | 2015 | 3 | 0.120 |
Why?
| | Heart | 1 | 2019 | 637 | 0.120 |
Why?
| | Protein Stability | 3 | 2012 | 162 | 0.120 |
Why?
| | Splenomegaly | 1 | 2015 | 15 | 0.120 |
Why?
| | Procollagen-Proline Dioxygenase | 2 | 2011 | 21 | 0.120 |
Why?
| | Muscle Contraction | 1 | 2018 | 422 | 0.120 |
Why?
| | Hemorrhage | 1 | 2019 | 678 | 0.120 |
Why?
| | Cardiac Output | 2 | 2012 | 156 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 524 | 0.110 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2015 | 145 | 0.110 |
Why?
| | Altitude | 1 | 2018 | 461 | 0.110 |
Why?
| | Cell-Free System | 3 | 2011 | 48 | 0.110 |
Why?
| | Prostatic Neoplasms | 1 | 2021 | 1016 | 0.110 |
Why?
| | Excipients | 2 | 2024 | 52 | 0.110 |
Why?
| | Endotoxemia | 1 | 2014 | 86 | 0.100 |
Why?
| | Cross-Linking Reagents | 2 | 2012 | 205 | 0.100 |
Why?
| | Muscle Proteins | 1 | 2015 | 220 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 3794 | 0.100 |
Why?
| | Exercise | 1 | 2024 | 1924 | 0.100 |
Why?
| | Models, Molecular | 3 | 2020 | 1492 | 0.100 |
Why?
| | Reactive Oxygen Species | 2 | 2007 | 596 | 0.100 |
Why?
| | Creatinine | 2 | 2012 | 491 | 0.100 |
Why?
| | Malaria | 1 | 2013 | 59 | 0.100 |
Why?
| | Membrane Proteins | 3 | 2020 | 1119 | 0.100 |
Why?
| | Transcriptome | 2 | 2018 | 887 | 0.100 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 30 | 0.100 |
Why?
| | Infusion Pumps | 1 | 2012 | 31 | 0.100 |
Why?
| | Adult | 5 | 2023 | 35572 | 0.100 |
Why?
| | Spin Labels | 1 | 2012 | 47 | 0.100 |
Why?
| | Neutrophils | 1 | 2018 | 1205 | 0.100 |
Why?
| | Cardio-Renal Syndrome | 1 | 2012 | 12 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1486 | 0.100 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2023 | 97 | 0.100 |
Why?
| | Cohort Studies | 2 | 2021 | 5420 | 0.100 |
Why?
| | Glycolysis | 2 | 2025 | 311 | 0.090 |
Why?
| | Dimerization | 2 | 2010 | 192 | 0.090 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 389 | 0.090 |
Why?
| | Catechin | 1 | 2011 | 24 | 0.090 |
Why?
| | Tyrosine | 1 | 2012 | 223 | 0.090 |
Why?
| | Occludin | 1 | 2011 | 11 | 0.090 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2011 | 15 | 0.090 |
Why?
| | Iron Chelating Agents | 1 | 2011 | 18 | 0.090 |
Why?
| | Cytokines | 2 | 2021 | 2017 | 0.090 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2011 | 77 | 0.090 |
Why?
| | Area Under Curve | 1 | 2012 | 304 | 0.090 |
Why?
| | Surface Plasmon Resonance | 2 | 2008 | 88 | 0.090 |
Why?
| | Claudins | 1 | 2011 | 25 | 0.090 |
Why?
| | Basilar Artery | 2 | 2021 | 6 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2018 | 3381 | 0.090 |
Why?
| | Heart Diseases | 1 | 2014 | 350 | 0.090 |
Why?
| | Erythrocyte Aggregation | 1 | 2010 | 3 | 0.080 |
Why?
| | Filtration | 1 | 2010 | 67 | 0.080 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 132 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1472 | 0.080 |
Why?
| | Pyridones | 1 | 2011 | 159 | 0.080 |
Why?
| | Biophysics | 1 | 2010 | 68 | 0.080 |
Why?
| | Fatty Acids | 2 | 2023 | 427 | 0.080 |
Why?
| | Oxygen Consumption | 2 | 2024 | 672 | 0.080 |
Why?
| | Aorta | 1 | 2012 | 411 | 0.080 |
Why?
| | Cellular Senescence | 1 | 2011 | 181 | 0.080 |
Why?
| | Pneumonia | 1 | 2015 | 616 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2013 | 402 | 0.080 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2008 | 8 | 0.080 |
Why?
| | Phosphoproteins | 1 | 2011 | 332 | 0.080 |
Why?
| | Globins | 1 | 2008 | 21 | 0.080 |
Why?
| | alpha-Globins | 1 | 2008 | 9 | 0.080 |
Why?
| | Cells, Cultured | 3 | 2015 | 4083 | 0.080 |
Why?
| | Buffers | 1 | 2008 | 56 | 0.070 |
Why?
| | Hemin | 2 | 2021 | 4 | 0.070 |
Why?
| | Lasers | 2 | 2005 | 132 | 0.070 |
Why?
| | Ferric Compounds | 1 | 2008 | 47 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2009 | 179 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2119 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2017 | 443 | 0.070 |
Why?
| | Drug Stability | 1 | 2007 | 159 | 0.070 |
Why?
| | Tissue Engineering | 1 | 2011 | 396 | 0.070 |
Why?
| | Adenosine Triphosphate | 2 | 2010 | 480 | 0.070 |
Why?
| | Binding Sites | 2 | 2011 | 1252 | 0.070 |
Why?
| | Methionine | 1 | 2006 | 158 | 0.060 |
Why?
| | Pentetic Acid | 1 | 2005 | 13 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 548 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2018 | 331 | 0.060 |
Why?
| | Molecular Structure | 1 | 2007 | 482 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2142 | 0.060 |
Why?
| | Raffinose | 1 | 2005 | 23 | 0.060 |
Why?
| | Protein Structure, Quaternary | 2 | 2018 | 122 | 0.060 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 423 | 0.060 |
Why?
| | Cysteine | 1 | 2006 | 195 | 0.060 |
Why?
| | Cystine | 1 | 2005 | 17 | 0.060 |
Why?
| | Child | 2 | 2023 | 20882 | 0.060 |
Why?
| | Coronary Vessels | 2 | 2018 | 241 | 0.060 |
Why?
| | Time Factors | 2 | 2015 | 6556 | 0.060 |
Why?
| | Scattering, Radiation | 1 | 2005 | 100 | 0.060 |
Why?
| | Peptides | 1 | 2010 | 925 | 0.060 |
Why?
| | Antimalarials | 1 | 2024 | 30 | 0.060 |
Why?
| | Kinetics | 1 | 2008 | 1642 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2021 | 697 | 0.060 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2024 | 9 | 0.060 |
Why?
| | Chlorides | 1 | 2005 | 139 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2017 | 2391 | 0.060 |
Why?
| | Particle Size | 1 | 2005 | 355 | 0.050 |
Why?
| | Aerosols | 1 | 2025 | 170 | 0.050 |
Why?
| | Fish Oils | 1 | 2023 | 26 | 0.050 |
Why?
| | Acute Disease | 2 | 2021 | 980 | 0.050 |
Why?
| | Allografts | 1 | 2024 | 136 | 0.050 |
Why?
| | Heart Rate | 1 | 2007 | 801 | 0.050 |
Why?
| | Models, Chemical | 1 | 2004 | 265 | 0.050 |
Why?
| | Hemoglobin, Sickle | 1 | 2022 | 18 | 0.050 |
Why?
| | Risk Assessment | 1 | 2012 | 3240 | 0.050 |
Why?
| | Piperidines | 1 | 2004 | 198 | 0.050 |
Why?
| | Cercopithecidae | 1 | 2002 | 8 | 0.050 |
Why?
| | Regional Blood Flow | 1 | 2004 | 463 | 0.050 |
Why?
| | Drug Compounding | 1 | 2022 | 97 | 0.050 |
Why?
| | Protein Conformation | 1 | 2005 | 859 | 0.050 |
Why?
| | Administration, Intravenous | 1 | 2022 | 141 | 0.050 |
Why?
| | Hand | 1 | 2023 | 155 | 0.050 |
Why?
| | Biological Availability | 1 | 2002 | 147 | 0.050 |
Why?
| | Horses | 1 | 2022 | 107 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2024 | 1085 | 0.050 |
Why?
| | Young Adult | 1 | 2018 | 12426 | 0.050 |
Why?
| | Serum Albumin, Human | 1 | 2021 | 6 | 0.050 |
Why?
| | Platelet Aggregation | 1 | 2022 | 95 | 0.050 |
Why?
| | Platelet Activation | 1 | 2022 | 91 | 0.050 |
Why?
| | Triage | 1 | 2023 | 206 | 0.050 |
Why?
| | Cell Survival | 2 | 2018 | 1086 | 0.050 |
Why?
| | Etanercept | 1 | 2021 | 56 | 0.050 |
Why?
| | Carnitine | 1 | 2021 | 76 | 0.050 |
Why?
| | Nitrites | 2 | 2013 | 83 | 0.050 |
Why?
| | Cell Movement | 1 | 2005 | 945 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 52 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 222 | 0.040 |
Why?
| | Middle Aged | 2 | 2021 | 31150 | 0.040 |
Why?
| | ADAMTS13 Protein | 1 | 2020 | 6 | 0.040 |
Why?
| | Kynurenine | 1 | 2021 | 114 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 271 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 545 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1838 | 0.040 |
Why?
| | Monocytes | 1 | 2023 | 551 | 0.040 |
Why?
| | Mesocricetus | 1 | 2020 | 37 | 0.040 |
Why?
| | von Willebrand Factor | 1 | 2020 | 70 | 0.040 |
Why?
| | Blood Donors | 1 | 2021 | 96 | 0.040 |
Why?
| | Tryptophan | 1 | 2021 | 179 | 0.040 |
Why?
| | Administration, Oral | 1 | 2002 | 786 | 0.040 |
Why?
| | Cricetinae | 1 | 2020 | 277 | 0.040 |
Why?
| | Cardiopulmonary Bypass | 1 | 2021 | 202 | 0.040 |
Why?
| | Blood Banks | 1 | 2019 | 40 | 0.040 |
Why?
| | Lactic Acid | 1 | 2021 | 303 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2019 | 57 | 0.040 |
Why?
| | Cerebrospinal Fluid | 1 | 2019 | 92 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 149 | 0.040 |
Why?
| | Gadolinium | 1 | 2019 | 78 | 0.040 |
Why?
| | Organ Culture Techniques | 1 | 2019 | 154 | 0.040 |
Why?
| | Transfection | 1 | 2021 | 911 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 186 | 0.040 |
Why?
| | Intracranial Aneurysm | 1 | 2019 | 95 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 582 | 0.040 |
Why?
| | Tissue Donors | 1 | 2021 | 391 | 0.040 |
Why?
| | Blood Platelets | 1 | 2022 | 380 | 0.040 |
Why?
| | Endothelins | 1 | 2018 | 62 | 0.040 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2021 | 231 | 0.040 |
Why?
| | Vasodilation | 1 | 2021 | 476 | 0.040 |
Why?
| | Blood Safety | 1 | 2017 | 10 | 0.040 |
Why?
| | Hemodilution | 2 | 2008 | 9 | 0.040 |
Why?
| | Precision Medicine | 1 | 2022 | 387 | 0.040 |
Why?
| | Finite Element Analysis | 1 | 2018 | 72 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2021 | 505 | 0.040 |
Why?
| | Betacoronavirus | 1 | 2020 | 249 | 0.040 |
Why?
| | Viscosity | 1 | 2018 | 90 | 0.040 |
Why?
| | Metabolome | 1 | 2020 | 338 | 0.030 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 16 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2015 | 2058 | 0.030 |
Why?
| | Sheep | 1 | 2019 | 837 | 0.030 |
Why?
| | Protein Structure, Tertiary | 2 | 2011 | 840 | 0.030 |
Why?
| | Acclimatization | 1 | 2018 | 164 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1587 | 0.030 |
Why?
| | Transcription Factors | 1 | 2004 | 1651 | 0.030 |
Why?
| | Exchange Transfusion, Whole Blood | 2 | 2006 | 14 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 443 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2020 | 534 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1038 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2016 | 173 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2020 | 1876 | 0.030 |
Why?
| | Electric Impedance | 1 | 2015 | 101 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2015 | 2708 | 0.030 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2015 | 69 | 0.030 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2015 | 79 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2018 | 547 | 0.030 |
Why?
| | Drug Synergism | 1 | 2015 | 371 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 399 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2019 | 781 | 0.030 |
Why?
| | Apoptosis | 2 | 2014 | 2503 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 354 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2742 | 0.030 |
Why?
| | Mitochondria | 1 | 2019 | 877 | 0.030 |
Why?
| | Body Mass Index | 1 | 2021 | 2273 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2017 | 720 | 0.030 |
Why?
| | Lipoproteins, LDL | 1 | 2013 | 127 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 171 | 0.020 |
Why?
| | Phagocytosis | 1 | 2014 | 362 | 0.020 |
Why?
| | Iron Metabolism Disorders | 1 | 2011 | 4 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 1367 | 0.020 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2011 | 21 | 0.020 |
Why?
| | DNA Damage | 1 | 2014 | 384 | 0.020 |
Why?
| | Deferoxamine | 1 | 2011 | 20 | 0.020 |
Why?
| | Siderophores | 1 | 2011 | 11 | 0.020 |
Why?
| | Hydroxylation | 1 | 2011 | 42 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 2011 | 111 | 0.020 |
Why?
| | Cobalt | 1 | 2011 | 50 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2011 | 90 | 0.020 |
Why?
| | Bioreactors | 1 | 2011 | 43 | 0.020 |
Why?
| | Ligands | 1 | 2013 | 622 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 544 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 341 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2011 | 92 | 0.020 |
Why?
| | Tight Junctions | 1 | 2011 | 75 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2832 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 875 | 0.020 |
Why?
| | Hemoglobinuria | 1 | 2010 | 3 | 0.020 |
Why?
| | Glucose Oxidase | 1 | 2010 | 26 | 0.020 |
Why?
| | Caspase 3 | 1 | 2011 | 245 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 2871 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2010 | 197 | 0.020 |
Why?
| | Nitroso Compounds | 1 | 2009 | 5 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3076 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7131 | 0.020 |
Why?
| | Nitric Oxide Donors | 1 | 2009 | 19 | 0.020 |
Why?
| | Blood Component Transfusion | 1 | 2010 | 82 | 0.020 |
Why?
| | Astrocytes | 1 | 2011 | 201 | 0.020 |
Why?
| | Canada | 1 | 2010 | 350 | 0.020 |
Why?
| | Glutathione | 1 | 2010 | 348 | 0.020 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2010 | 259 | 0.020 |
Why?
| | Nitric Oxide Synthase | 1 | 2008 | 237 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 769 | 0.020 |
Why?
| | Heart Failure | 1 | 2021 | 2149 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2008 | 235 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2679 | 0.020 |
Why?
| | Peroxides | 1 | 2006 | 19 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 847 | 0.020 |
Why?
| | Erythrocyte Membrane | 1 | 2006 | 49 | 0.020 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2005 | 13 | 0.020 |
Why?
| | Osmotic Pressure | 1 | 2005 | 35 | 0.020 |
Why?
| | Rabbits | 1 | 2006 | 778 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2009 | 575 | 0.010 |
Why?
| | Endocytosis | 1 | 2005 | 163 | 0.010 |
Why?
| | Endosomes | 1 | 2005 | 126 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 361 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1418 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 692 | 0.010 |
Why?
| | United States | 1 | 2017 | 13900 | 0.010 |
Why?
|
|
Buehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|